Analysis of risk factors for chronic subdural haematoma recurrence after burr hole surgery: Optimal management of patients on antiplatelet therapy

British Journal of Neurosurgery

Volumn 28, Issue 2, 2014, Pages 204-208

  Okano, Atsushi ^a   Oya, Soichi ^a   Fujisawa, Naoaki ^a   Tsuchiya, Tsukasa ^a   Indo, Masahiro ^a   Nakamura, Takumi ^a   Chang, Han Soo ^a   Matsui, Toru ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anticoagulant drug; Antiplatelet drug; Chronic subdural haematoma; Recurrence

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN INFARCTION; BURR HOLE SURGERY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTIVE SURGERY; FEMALE; HEAD INJURY; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; NEUROSURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SEIZURE; SUBDURAL HEMATOMA; SURGICAL RISK;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HEMATOMA, SUBDURAL, CHRONIC; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROSURGICAL PROCEDURES; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; THERAPEUTIC IRRIGATION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TREPHINING; YOUNG ADULT;

EID: 84896335934     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688697.2013.829563     Document Type: Article

References (27)

1. Karibe H, Kameyama M, Kawase M, et al. [Epidemiology of chronic subdural hematoma]. No Shinkei Geka 2011; 39:1149-53 (Jpn).
2. El-Kadi H, Miele VJ, Kaufman HH. Prognosis of chronic subdural hematomas. Neurosurg Clin N Am 2000; 11:553-67. (Pubitemid 30602988)
3. Ernestus RI, BeldzinskiP,LanfermannH,KlugN.Chronicsubdural hematoma: surgical treatment and outcome in 104 patients. Surg Neurol 1997; 48:220-5. (Pubitemid 27377371)
4. Markwalder TM. Chronic subdural hematomas: a review. J Neurosurg 1981; 54:637-45. (Pubitemid 11156357)
5. Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that inf uence their postoperative recurrence. J Neurosurg 2001; 95:256-62. (Pubitemid 32799747)
6. Torihashi K, Sadamasa N, Yoshida K, et al. Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 2008; 63:1125-9; discussion 1129.
7. Wakai S, Hashimoto K, Watanabe N, et al. Efcacy of closed-system drainage in treating chronic subdural hematoma: a prospective comparative study. N eurosurgery 1990; 26:771-3. (Pubitemid 20152597)
8. Abouzari M, Rashidi A, Rezaii J, et al. Te role of postoperative patient posture in the recurrence of traumatic chronic subdural hematoma after burr-hole surgery. Neurosurgery 2007; 61:794-7; discussion 797. (Pubitemid 350073294)
9. Asano Y, Hasuo M, Takahashi I, Shimosawa S. [Recurrent cases of chronic subdural hematoma-its clinical review and serial CT fndings]. No To Shinkei 1992; 44:827-31 (Jpn).
10. Forster MT, Mathé AK, Senft C, et al. Te infuence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma. J Clin Neurosci 2010; 17:975-9.
11. Fukuhara T, Gotoh M, Asari S, Ohmoto T, Akioka T. Te relationship between brain surface elastance and brain reexpansion after evacuation of chronic subdural hematoma. Surg Neurol 1996; 45:570-4. (Pubitemid 26262179)
12. Ko BS, Lee JK, Seo BR, et al. Clinical analysis of risk factors related to recurrent chronic subdural hematoma. J Korean Neurosurg Soc 2008; 43:11-15.
13. Lindvall P, Koskinen LO. Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. J Clin Neurosci 2009; 16:1287-1290.
14. Mori K, Maeda M. Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo) 2001; 41:371-81. (Pubitemid 32785798)
15. Nakaguchi H, Tanishima T, Yoshimasu N. Relationship between drainage catheter location and postoperative recurrence of chronic subdural hematoma after burr-hole irrigation and closed-system drainage. J Neurosurg 2000; 93:791-5. (Pubitemid 32803401)
16. Oishi M, Toyama M, Tamatani S, Kitazawa T, Saito M. Clinical factors of recurrent chronic subdural hematoma. Neurol Med Chir (Tokyo) 2001; 41:382-6. (Pubitemid 32785799)
17. Yamamoto H, Hirashima Y, Hamada H, et al. Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 2003; 98:1217-21. (Pubitemid 36617924)
18. Baechli H, Nordmann A, Bucher HC, Gratzl O. Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study. Neurosurg Rev 2004; 27:263-6. (Pubitemid 39350192)
19. Sim Y-W, Min K-S, Lee M-S, Kim Y-G, Kim D-H. Recent changes in risk factors of chronic subdural hematoma. J Korean Neurosurg Soc 2012; 52:234-39.
20. Palinski W. New evidence for benef cial ef ects of statins unrelated to lipid lowering. Arterioscler T romb Vasc Biol 2001; 21:3-5. (Pubitemid 32061921)
21. Tapia-Péez JH, Sanchez-Aguilar M, Schneider T. Te role of statins in neurosurgery. Neurosurg Rev 2010; 33:259-70; discussion 270.
22. Wang CY, Liu PY, Liao JK. Pleiot ropic ef ects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med 2008; 14:37-44.
23. Berghauser Pont LM, Dammers R, Schouten JW, Lingsma HF, Dirven CM. Clinical factors associated with outcome in chronic subdural hematoma: a retrospective cohort study of patients on pre-operative corticosteroid therapy. Neurosurgery 2011;
24. Frati A, Salvati M, Mainiero F, et al. Infammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 2004; 100:24-32. (Pubitemid 38017811)
25. Hong HJ, Kim YJ, Yi HJ, et al. Role of angiogenic growth factors and inf ammatory cytokine on recurrence of chronic subdural hematoma. Surg Neurol 2009; 71:161-5; discussion 165-6.
26. Stanisic M, Lyngstadaas SP, Pripp AH, et al. Chemokines as markers of local inf ammation and angiogenesis in patients with chronic subdural hematoma: a prospective study. Acta Neurochir (Wien) 2012; 154:113-20.
27. Weigel R, Hohenstein A, Schlickum L, Weiss C, Schilling L. Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism. Neurosurgery 2007; 61:788-92; discussion 792-3. (Pubitemid 350073290)